LOGO
LOGO

Entrada's Duchenne Drug Trial Results Set For October

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024 lt

Duchenne muscular dystrophy (DMD), commonly known as Duchenne, is a rare disorder resulting from mutations in the DMD gene, which is responsible for producing the dystrophin protein. These mutations result in insufficient production of dystrophin.

Dystrophin is crucial for preserving the structural integrity and functionality of muscle cells. The absence of functional dystrophin leads to a gradual decline in muscle strength, affecting mobility and leading to heart and respiratory issues, which significantly increase mortality rates.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

Latest Updates on COVID-19